BSX - Boston Scientific Corp.

BSX

$43.15 1.82 (-4.04%)

After Hours: $43.15 +0.00 (+0.00%)

Last updated: Sep 10, 2026 20:11

52-Week Range

$43.15

$42.20 $43.15 $105.72

Fundamentals Overview

Boston Scientific Corp. is near the low of its 52-week range with attractive valuation, trending downward today.

Valuation attractive

P/E 17.9 PEG 0.39 P/B 2.54 P/S 3.13

Profitability

ROE 14.94% Net margin 17.5%

Risk (Beta)

0.6 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 61% confidence Risk: Lower Volatility — Beta 0.6. Diversify and only invest what you can afford to lose.

Supporting (Buy):

PEG 0.39 (growth vs price)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$65.16B

P/E (TTM)

17.91

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$42.20 - $105.72

Volume vs Avg

N/A

Beta

0.6

About

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions glo...

Sector: stocks

Headquarters:

Website: www.bostonscientific.com

Beta: 0.6 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	17.91
PEG (TTM)	0.39
P/B (TTM)	2.54
P/S (TTM)	3.13
Profitability
ROE (TTM)	14.94%
ROA (TTM)	8.35%
Revenue growth (YoY)	N/A
Net margin (TTM)	17.5%
Gross margin (TTM)	69.5%
Operating margin (TTM)	19.78%
Debt to equity (TTM)	0.51

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for BSX.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.